Clinical Trial

Biomarkers for Babies and Young Children With Ataxia Telangiectasia

Study acronym: BOBCAT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to identify progressive changes of quantitative brain and lung imaging, serum and movement-related biomarkers reflecting disease progression in pre-symptomatic infants and very young children (0-5 yo) with a genetic diagnosis of A-T, that could be used in future early-life intervention trials.
Trial Details
NCT Number NCT07709728
Lead Sponsor University of Nottingham
Conditions Ataxia Telangiectasia
Enrollment 56 participants
Start Date 2026-09-01
Primary Completion 2029-08-31 (estimated)
Study Completion 2029-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-16